Home | Welcome to Contract Pharma   
Last Updated Saturday, May 30 2015


AMRI Completes Cedarburg Acquisition

Published April 7, 2014
AMRI has completed the acquisition of Cedarburg Pharmaceuticals, Inc. for a total consideration of $41 million, including assumption of certain liabilities.
The acquisition of Cedarburg, a contract developer and manufacturer of technically complex API's for both generic and branded drug products, is part of AMRI's strategy to expand its presence as a supplier of custom and complex drug development services and product. Customers will now have access to expanded resources, including development of complex API, expanded scale-up capabilities and large-scale manufacturing.

blog comments powered by Disqus

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On